News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SHARP PHILLIP A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/24/2023 |
4
| SHARP PHILLIP A (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 6,027 shares
@ $0
Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
| 05/19/2023 |
4
| SHARP PHILLIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 3,454 options to buy
@ $189.87, valued at
$655.8k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2021 |
4
| SHARP PHILLIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 4,032 options to buy
@ $171.95, valued at
$693.3k
|
|
| 06/10/2021 |
4
| SHARP PHILLIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $6.3, valued at
$110.3k
|
|
| 05/25/2021 |
4
| SHARP PHILLIP A (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 3,374 shares
@ $0
Granted 6,748 options to buy
@ $45.28, valued at
$305.5k
|
|
| 12/22/2020 |
4
| SHARP PHILLIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Gifted 235,633 shares
@ $0
Gifted 235,633 shares
@ $0 |
|
| 11/30/2020 |
4
| SHARP PHILLIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 11,523 shares
@ $124.3, valued at
$1.4M
Sold 15,715 shares
@ $125.05, valued at
$2M
Sold 2,117 shares
@ $126.16, valued at
$267.1k
Sold 645 shares
@ $127.44, valued at
$82.2k
Exercised 30,000 options to buy
@ $9.3, valued at
$279k
|
|
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| SHARP PHILLIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.17, valued at
$160.5k
|
|
| 05/26/2020 |
4
| SHARP PHILLIP A (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 28,888 options to buy
@ $37.06, valued at
$1.1M
|
|
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2019 |
4
| SHARP PHILLIP A (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Converted 88,888 shares
@ $0
Converted 44,444 shares
@ $0
Converted 44,444 shares
@ $0
Converted 44,444 shares
@ $0
Converted 88,888 convertible preferred
@ $0
Converted 44,444 convertible preferred
@ $0
Converted 44,444 convertible preferred
@ $0
Converted 44,444 convertible preferred
@ $0 |
|
| 10/11/2019 |
4
| SHARP PHILLIP A (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 22,222 options to buy
@ $20, valued at
$444.4k
|
|
| 07/02/2019 |
4
| SHARP PHILIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,000 options to buy
@ $72.01, valued at
$648.1k
|
|
| 06/12/2019 |
4
| SHARP PHILIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 11,000 options to buy
@ $5.6, valued at
$61.6k
|
|
| 04/17/2019 |
4
| SHARP PHILIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 11,800 shares
@ $87.86, valued at
$1M
Sold 2,200 shares
@ $89.03, valued at
$195.9k
Sold 400 shares
@ $89.97, valued at
$36k
Sold 600 shares
@ $91.4, valued at
$54.8k
Exercised 15,000 options to buy
@ $22.09, valued at
$331.4k
|
|
| 06/22/2018 |
4
| SHARP PHILIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,000 options to buy
@ $105.26, valued at
$947.3k
|
|
| 06/15/2018 |
4
| SHARP PHILIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 11,000 options to buy
@ $12.95, valued at
$142.5k
|
|
| 03/14/2018 |
4
| SHARP PHILIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 15,000 shares
@ $149, valued at
$2.2M
Exercised 15,000 options to buy
@ $21.35, valued at
$320.3k
|
|
| 03/13/2018 |
4
| SHARP PHILIP A (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 15,000 shares
@ $129, valued at
$1.9M
Exercised 15,000 options to buy
@ $27.28, valued at
$409.2k
|
|
| 06/12/2017 |
4
| SHARP PHILIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 11,000 options to buy
@ $14.26, valued at
$156.9k
|
|
| 06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/19/2016 |
4
| SHARP PHILIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc. |
| 07/06/2016 |
4
| SHARP PHILIP A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Converted 146,666 shares
@ $0
Converted 40,000 shares
@ $0
Converted 40,000 shares
@ $0
Converted 40,000 shares
@ $0
Converted 550,000 preferred shares
@ $0
Converted 150,000 preferred shares
@ $0
Converted 150,000 preferred shares
@ $0
Converted 150,000 preferred shares
@ $0 |
|
| 06/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|